Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 23Neoplasm Metastasis 7Brain Neoplasms 5Prostatic Neoplasms 4Oligodendroglioma 2Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Venous Thromboembolism 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Meningioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Liposarcoma 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Ependymoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1

Interventions

Magnetic Resonance Spectroscopy 6X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Biopsy 5Cyclophosphamide 3ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Temozolomide 2Etoposide 2tazemetostat 1pembrolizumab 1palbociclib 1omburtamab I-131 1olaparib 1etoposide phosphate 1dostarlimab 1abemaciclib 1Vemurafenib 1Triiodothyronine 1Surgical Procedures, Operative 1Sirolimus 1Radiation 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Ependymoma × abemaciclib × Clear all
NCT03220646 2025-07-09

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
64 enrolled
CNS

Astrocytoma, Brain Neoplasms, Ependymoma, Meningioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡